MS

Marcin Szumowski

President & CEO

OncoArendi Therapeutics

Warsaw, Masovian Voivodeship


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
OncoArendi Therapeutics
Industry
research
Employees
76.0
Seniority
C suite

Technologies

Outlook Microsoft Office 365 Google Tag Manager Mobile Friendly Woo Commerce reCAPTCHA WordPress.org Apache MailChimp YouTube AI

Keywords

small molecule drug discovery immunooncology medicinal chemistry pharmaceuticals inflammatory diseases fibrotic diseases chitinase arginase respiratory diseases cancer immunotherapy small molecule immunomodulators biotechnology research biotechnology small molecule drugs clinical trials cancer therapies first-in-class chitinase inhibitors arginase inhibitors oatd-01 oatd-02 drug discovery rna platform protein targets neoplastic diseases fibrosis treatments therapeutic development pharmaceutical partnerships clinical development anti-inflammatory compounds mrna targeting immuno-oncology therapeutic innovations translational science pulmonary sarcoidosis idiopathic pulmonary fibrosis metabolic diseases exclusivity agreements target identification preclinical studies research collaborations undrugged targets target validation drug candidates biopharmaceuticals publicly traded investor relations research institutions pipeline development medical research disease modulation chronic diseases biomarker discovery phase i trials phase ii trials small molecule compounds unexplored proteins molecule design drug efficacy biotechnology competitive landscape medical health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans